Celsion Jumps On Interim Data On Cancer Drug
February 20, 2015 at 11:45 AM EST
Celsion Corporation (NASDAQ: CLSN) shares gained sharply Friday after the company said interim data from an early trial of its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.